Objective: To review current literature that supports gender identity having a biologic basis. .
Introduction
Gender identity is a fundamental human attribute which has a profound impact on personal well-being. Transgender individuals are those whose lived and identified gender identity differs from their natal sex. Various etiologies for transgender identity have been proposed.
Misconceptions which assume that gender identity can be altered still exist. However, clinical experience with treatment of transgender persons over the years has clearly demonstrated that the best outcomes with these individuals are achieved with their requested hormone therapy and surgical sexual transition, as opposed to psychiatric intervention alone (1) . In this manuscript we will review the data which support a fixed, biological basis for gender identity.
Methods
This traditional literature review was conducted using a search of PubMed and Google Scholar for the following key words: gender identity, gender dysphoria, transsexual, transgender, transmen, transwomen.
Results

Disorders of Sex Development (DSD)
A seminal study by Meyer-Bahlburg et al involving outcomes of XY individuals raised as females due to severe non-hormonal, anatomic abnormalities of sex development has provided the most convincing evidence that gender identity is fixed (2) . These congenital abnormalities include penile agenesis, cloacal exstrophy, and penile ablation. For many years, female gender assignment along with surgical feminization was the dominant approach for these patients. In this study, it was observed that 78% of all female-assigned 46 XY patients were living as females While the majority of these patients did not initiate a gender change to male, none of the 15 maleraised 46 XY patients initiated a gender change to female. Thus, risk of questioning gender identity was higher in those patients raised as females than in those raised as males among 46 XY subjects with one of these conditions. A study by the same group that examined the degree of satisfaction with surgical intervention reported by patients with 46 XY genotype also found that those subjects raised as boys were considerably more comfortable with their gender identity (3).
Another seminal study relevant to this topic was by Reiner and Gearhart (4) in their review of 16 XY genotype subjects with cloacal exstrophy who underwent female gender reassignment surgery. Out of the 14 individuals raised as girls, 4 announced they were male and 4 later chose to live as boys when they became aware of their genotype. The 2 individuals who were raised as males identified as males throughout life. The sexual behavior and attitudes of all 16 subjects ultimately reflected strong masculine characteristics regardless of gender assignment.
Thus, children who were born genetically and hormonally male identified as males despite being raised as females and undergoing feminizing genitoplasty at birth. Although cohort size in these studies is small, these data provide the strongest evidence for biological underpinnings of gender identity.
In congenital adrenal hyperplasia (CAH) the adrenal glands produce excessive amounts of androgens, causing genital virilization with a spectrum of different phenotypes in 46 XX neonates.
Dessens et al (5) showed that the prevalence of male gender identity in 46 XX female-raised subjects with CAH is higher than the prevalence of FTM transgender individuals in the general population of chromosomal females. In this study, the large majority (95%) of 250 female-raised patients later maintained a female gender identity. However, 13 (5.2%) had serious problems with their gender identity. 5 alpha-reductase-2 and 17-beta-hydroxy-steroid dehyrogenase-3 deficiencies are similar conditions in which synthesis and conversion of testosterone to dihydrotestosterone (DHT) is inhibited, , preventing development of external male genitalia and resulting in potential genital ambiguity. As with CAH, affected individuals are often raised as females. In a study of affected subjects, gender role changes were reported in 56-63%
of cases with 5 alpha-reductase-2 and 39-64% of cases with 17-beta-hydroxy-steroid dehydrogenase-3 who were raised as girls (6) . These data support the concept that gender identity might be attributed to hormone milieu during intrauterine development on some occasions.
Data from disorders of sexual development highlight the potential influence of abnormal hormone exposure on development of transgender identity in some individuals. However, it is important to note that most transgender individuals develop a gender identity which cannot be be explained by atypical sexual differentiation. It is possible for individuals with normal sexual differentiation to develop transgender identity later in life.
Neuroanatomical Differences
Many of the current hypotheses for the biological origin of transgender identity are based on atypical sexual differentiation of the brain. The perception of one's own gender is linked to sexual differentiation of the brain, which, in transgender individuals, differs from the body phenotype (7). Regarding transgender identity, Swaab et al have proposed that this discrepancy could be due to the fact that sexual differentiation of the brain takes place only after sexual differentiation of gonads in early fetal life (8) . Along these lines, the degree of masculinization of the genitals may not reflect that of the brain .
The notion of transgender-specific cerebral phenotypes has been further supported by postmortem brain studies investigating the underlying neuroanatomical correlates of gender identity (9, 10, 12) . The vast majority of these studies have compared particular regions of interest only in MTF transgender individuals (13, 14, 15) . These studies support the hypothesis that atypical cerebral networks in transgender individuals have a neuroanatomical basis. Studies have examined both grey and white matter areas of the brain, as follows:
Grey Matter Studies
Studies involving grey matter in transgender individuals have provided the strongest neuroanatomical case for transgender gender identity. Postmortem brain studies suggest that some subcortical structures are feminized in MTF transgender individuals. One of the earliest and most influential studies in this area involved the bed nucleus of the stria terminalis (BSTc), which was reported to be a sexually dimorphic nucleus in humans with a larger volume in males than in females. In 1995, Zhou et al found that the size and the number of neurons in the BSTc of 6 MTF estrogen-treated transgender individuals was typical for the size and neuron numbers found generally in control females (9) .The authors further reported that these findings could not be explained by differences in adult sex hormone levels. The following two studies were unique from the aforementioned ones because they included both MTF and FTM transgender individuals who had not received hormone treatment.
Zubiaurre et al reported that FTM transgender individuals showed evidence of subcortical gray matter masculinization in the right putamen, while MTF transgender individuals had feminized cortical thickness (18) . In 2013, a study by Simon et al found differences in grey matter in 17
living transgender subjects compared with controls (19) . Differences were seen in transgender patients in the cerebellum, angular gyrus, and parietal lobe compared with controls, independent of their biological gender.
White Matter Studies
Although an early study by Emory et al (20) found no difference in the whole corpus callosum or the splenium region between MTF and FTM transgender individuals, the following MRI studies of white matter brain characteristics of transgender individuals have suggested a strong neuroanatomical explanation for transgender identity . Yokota et al reported that the pattern of corpus callosum shape in both FTM and MTF transgender individuals was closer to subjects with shared gender identities than to subjects who shared the same natal sex (21).
Among FTM transgender individuals who had not received hormone treatment, certain white matter fasciculi involved in higher cognitive functions were closer to the pattern of control males than to control females (22 
Genetic Factors and Exposures
Although limited in size and scope, the involvement of genetic factors in transgender identity is supported by small studies of gene abnormalities associated with steroid hormones, twin case studies, neuroproteins, and prenatal exposures.
Steroid Hormone Genetics
Select genes have been associated with transgender identity. Although these studies have There have been several small case reports of atypical sex chromosomes in transgender individuals. The most common association reported was with disomy-Y (47, XXY), however no statistically significant association between particular genes has been noted (29) . . Two recent studies of MTF and FTM transgender individuals reported that aneuplodies are slightly more common in transgender individuals than in the general population but neither was controlled. In the first, karyotype abnormalities were found in 2.5% of the 368 transgender individuals studied (30) . A second study of 302 transgender individuals also showed a low overall incidence (1.5%) of chromosomal abnormalities (31) .
Twin studies
Twin literature supports the potential contribution of genetic factors to the development of transgender identity. In two separate retrospective studies of twin pairs, Bailey et al and
Coolidge et al demonstrated a strong heritable component among twins with transgender identity (32, 33) . A similar study by Hylens et al of 23 twin pairs showed that 9 out of 23 monozygotic twin pairs were concordant for transgender identity, in contrast to no concordance among the DOI:10.4158/EP14351.RAdizygotic twin pairs (34) . Two small studies o studies (35, 36) have also demonstrated a higher concordance for transgender identity among monozygotic twins versus dizygotic twins.
Nevertheless, the overall prevalence of monozyotic twins discordant for transgender identity still outnumbers those who are condordant.
Neuroproteins
Brain-derived neurotrophic factor (BDNF) is a member of the growth factor family which is involved in synaptic plasticity and neuronal development. Altered BDNF signaling is thought to be a contributor to psychiatric conditions. Fontanari et al (37) reported that serum BDNF levels were 15% lower in an uncontrolled study of 45 MTF transgender individuals. However, all study subjects were treated with hormones and no female subjects were included. 
Conclusion
Current data suggest a biological etiology for transgender identity. Studies of DSD patients and neuroanatomical studies provide the strongest evidence for the organic basis of transgender identity. Sample sizes of the majority of studies to date on this subject are small, and conclusions must be interpreted with caution. Further research is required to assign specific biological mechanisms for gender identity. 
